Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis (Connect-MS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Daan de Jong, MD MSc
- Phone Number: +31625716307
- Email: connectms@amsterdamumc.nl
Study Contact Backup
- Name: Eva Strijbis, MD PhD
- Phone Number: +31625716307
- Email: connectms@amsterdamumc.nl
Study Locations
-
-
Gelderland
-
Arnhem, Gelderland, Netherlands, 6815AD
- Rijnstate Arnhem
-
Contact:
- Jop Mostert, MD PhD
-
-
Limburg
-
Geleen, Limburg, Netherlands, 6162BG
- Zuyderland Medical Center
-
Contact:
- Oliver Gerlach, MD PhD
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands, 1081HV
- Amsterdam UMC
-
Contact:
- Daan de Jong, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Have signed non-WMO informed consent
- Be able to comply with the study protocol, as judged by the investigator.
- Have a minimum age of 18 years.
- Have a definite diagnosis multiple sclerosis (either RRMS, SPMS or PPMS) according to the revised 2017 McDonald criteria. (Thompson et al., 2018)
- Willing and able to install and use MS Sherpa and NeuroKeys on a privately-owned cell phone.
Since this is an observational cohort study, concomitant participation in any intervention trial is allowed.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of digital monitoring questionnaire: healthcare provider
Time Frame: At each clinical consultation throughout the two year study follow-up
|
This questionnaire is a self-developed questionniare that focusses on the impact of digital monitoring on clinical consultation and choices during the consult from the perspective of a healthcare provider.
|
At each clinical consultation throughout the two year study follow-up
|
|
Adherence to the MS Sherpa application.
Time Frame: Throughout the two year follow-up period. Assessments scheduled weekly.
|
Adherence to the MS sherpa application defined as number of completed from scheduled assessments.
|
Throughout the two year follow-up period. Assessments scheduled weekly.
|
|
Application outcomes of MS Sherpa
Time Frame: Throughout the two year follow-up period. Assessments scheduled weekly.
|
Outcomes of the MS sherpa application (smartphone SDMT, smartphone 2MWT, patient-reported questionnaire)
|
Throughout the two year follow-up period. Assessments scheduled weekly.
|
|
Impact of digital monitoring questionnaire: patient
Time Frame: At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
This questionnaire is a self-developed questionniare that focusses on the impact of digital monitoring on clinical consultation and choices during the consult from the perspective of a patient.
|
At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
|
Adherence to the Neurokeys application
Time Frame: Daily passive monotring throughout the two year follow-up period.
|
Adherence to the NeuroKeys application.
|
Daily passive monotring throughout the two year follow-up period.
|
|
Medical consumption questionnaire (iMCQ)
Time Frame: At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
The iMTA Medical Consumption Questionnaire measures the direct healthcare costs in the last three months based on the healthcare consumption (such as hospitalisations, consultations with doctors, use of care at home, use of specialised transportation etc).
|
At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
|
Productivity costs questionnaire (iPCQ)
Time Frame: At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
The iMTA Productivity Cost Questionnaire measures the indirect nonmedical costs based on productivity loss by assessing the employment situation and short- and long term sick absence due to MS or MS-related treatment in the last four weeks.
|
At each clinical consultation throughout the two year study follow-up. Standard care is yearly clinical consultation.
|
|
Application outcomes of Neurokeys
Time Frame: Continously and daily throughout the two year follow-up period.
|
Outcomes of the NeuroKeys application (i.e.
clusters of keystroke dynamics).
|
Continously and daily throughout the two year follow-up period.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Joep Killestein, Prof, Amsterdam UMC
- Principal Investigator: Eva Strijbis, MD PhD, Amsterdam UMC
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024.0188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.